http://www.sptimes.com/2004/06/11/State/Senate_race_opponents.shtml Fellow candidates are criticizing the Democratic congressman for accepting $41,200 in contributions from drug companies since 1994.
By ANITA KUMAR, Times Staff Writer
Published June 11, 2004
--------------------------------------------------------------------------------
A Broward County pharmaceutical company was pressing the federal government three years ago to approve a new generic heart drug, but the Food and Drug Administration was taking its time. So Andrx Corp. got an assist from its congressman, U.S. Rep. Peter Deutsch, D-Hollywood, who wrote a letter to the U.S. Food and Drug Administration urging swift approval.A week after Deutsch wrote the letter, three Andrx employees gave $1,000 each to his re-election campaign.It's unclear what role Deutsch's letter played in the FDA's approval two years later. But Andrx and its executives have been steady Deutsch supporters, donating at least $20,000 since 1992.
The total includes $5,000 to Deutsch's current campaign for the U.S. Senate. Andrx is not the only pharmaceutical company to support Deutsch. Since 1994, drug companies have given $41,200 to Deutsch or his political action committee, the Center for Responsive Politics reports. The donors include drug giants Bristol-Myers Squibb and GlaxoSmithKline, manufacturers of dozens of medicines including the antidepressant Paxil and the allergy drug Flonase. Deutsch's pharmaceutical ties have come under fire by his leading Democratic opponents, former state education commissioner Betty Castor and Miami-Dade County Mayor Alex Penelas. They say they won't take money from drugmakers and have called on Deutsch to do the same.
<snip>
Penelas returned $500 from an employee of COS Pharmaceuticals earlier this year and has not accepted any other donations from drug makers, said spokeswoman Danae Jones. The pharmaceutical industry has contributed millions of dollars to members of Congress annually through soft money, political action committees and individuals. In the 2000-02 election cycle the industry donated almost $22-million, according to the Center for Responsive Politics.Jason Brodsky, an FDA spokesman in Washington, said the FDA's approval process is not based on lobbying, even by members of Congress. "The FDA's approval process is based on science," he said. On March 19, 2001, Deutsch and Republicans Dan Burton of Indiana and Ken Calvert of California, all members of the Government Reform Committee, wrote a letter to Secretary of Health and Human Services Tommy Thompson asking the FDA to intervene in a legal battle between Andrx and Biovail, manufacturer of blood pressure drug Tiazac.